홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

글루콘산아연

Zinc Gluconate

HCID 443445
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
4468-02-4
표준 SMILES
O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Zn+2]
InChIKey
WHMDKBIGKVEYHS-IYEMJOQQSA-L
분자식
C12H22O14Zn
평균 분자량
455.7 g/mol
단동위원소 질량
454.030097

개요

Zinc gluconate is a L-alpha-D-Hepp-(1->7)-L-alpha-D-Hepp-(1->3)-L-alpha-D-Hepp-(1->5)-alpha-Kdo.

이름 및 식별자

우선 이름
Zinc Gluconate
IUPAC
zinc bis((2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate)
현지명
글루콘산아연
영어명
Zinc gluconate
분자식
C12H22O14Zn
분자량
455.69

이름 및 동의어

ZINC GLUCONATE4468-02-4Zincum gluconicumZinc D-gluconate (1:2)Bis(D-gluconato-O1,O2) zincZinc gluconate (USP)U6WSN5SQ1ZDTXSID20894125ZinkgluconaatRubozineZinc, bis(D-gluconato-kappaO1,kappaO2)-, (T-4)-Zeuterin
이름 더 보기
글루콘산아연징크글루코네이트RubozincZinc gluconatZinc dihexonatezinc(ii) gluconatebis(D-gluconato-O1,O2)zincAids002622Aids-002622Zinc complexGivobio G Zn
MaxiGuardOticClrandClnzPlaqClnzBlue ScorpionClunia EasyDentOraZnBig RichardMedique ColdEeze

데이터베이스 식별자

CAS
4468-02-4
PubChem CID
443445
DTXSID
DTXSID20894125
ChEMBL
CHEMBL3833377
ChEBI
CHEBI:29708

물성

구조 계산 물성

극성 표면적
283 Ų
수소 결합 공여자 수
10
수소 결합 수용자 수
14
회전 가능 결합 수
8
무거운 원자 수
27
형식 전하
0
복잡도
165

실험 및 물리화학적 성질

Chemical ClassesOther Uses -> Food Additives
Cosmetics · 2건

Cosmetic ingredients (Zinc Gluconate) -> CIR (Cosmetic Ingredient Review)

Skin conditioning; Deodorant

Food AdditivesNUTRIENT SUPPLEMENT -> FDA Substance added to food
Color/FormPowder or granular
Solubilitymoderately soluble
Animal DrugsFDA approved animal drugs -> Active ingredient
Physical DescriptionSolid; [HSDB] White granular solid; [MSDSonline]

물리화학적 성질

녹는점
172 · 172-175 °C
끓는 점
319 °C · 319°C
밀도
1.44 · 1.44[at 20℃]
증기압
0 Pa · 0Pa at 20℃
저장 조건
-20 °C · Store at -20°C
용해도
물에 용해되며 무수 에탄올과 염화메틸렌에는 거의 용해되지 않습니다.

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 14.7% (39 of 266) of reports.

Danger

H318 (81.6%): Causes serious eye damage [Danger Serious eye damage/eye irritation]

P264+P265, P273, P280, P305+P354+P338, P317, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 266 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory Information · 3건

Chemical: Zinc, bis(D-gluconato-.kappa.O1,.kappa.O2)-, (T-4)-

REACH registered substance: Bis(D-gluconato-O1,O2)zinc (EC: 224-736-9)

Zinc, bis(D-gluconato-.kappa.O1,.kappa.O2)-, (T-4)-: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Zinc, bis(D-gluconato-O1,O2)-: Human health tier I assessment
Hazards Summary · 1건

Generally regarded as safe (GRAS) for use as dietary supplement and nutrient; [HSDB] At oral doses of 47 mg/kg, volunteers complained of distorted perceptions and nausea or vomiting; Intravenous LD50 (mouse) = 23.7 mg/kg; Oral LD50 (mouse) = 1290 mg/kg; [ChemIDplus] May cause irritation; [MSDSonline] See Zinc.

FDA RequirementsThis substance is generally recognized as safe when used as a nutrient and/or dietary supplement in accordance with good manufacturing or feeding practice.
Special Reports · 5건

Zinc and Health. Current Bibliographies in Medicine 98-3. Public Services Division/National Library of Medicine. 3619 citations January, 1990-June, 1998. Available from: http://www.nlm.nih.gov/archive/20040831/pubs/cbm/zinc.html as of November 2, 1998.

화학 및 산업

약리 정보

ATC Code · 2건

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Bionecessity · 1건

Recommended intakes may be increased and/or supplementation may be necessary in the following conditions (based on documented zinc deficiency): alcoholism; burns; cirrhosis of the liver; diabetes mellitus; eating disorders - anorexia nervosa, bulimia; gastrectomy; genetic disorders - celiac, Crohn's, diarrhea, sprue, ulcerative colitis; intestinal parasitism; malabsorption syndromes associated with pancreatic insufficiency - pancreatic disease, cystic fibrosis; renal diseases - nephrotic syndrome, renal failure, uremia; short bowel syndrome; skin disorders - exfoliative dermatoses, psoriasis; prolonged stress; prolonged trauma. /Zinc supplements/

Protein BindingPlease refer to DrugBank entry [DB01593]
Pharmacodynamics · 1건

Zinc is an important mineral found in almost every cell in the human body. It promotes the activity of about 100 enzymes. Zinc deficiency is often associated with an increased risk of infection. When they are used to treat the common cold, zinc supplements may interfere with rhinovirus cleavage or adhesion and may play a role in protecting plasma membranes from microbial toxins and complement.

Mechanism of ActionAlthough the mechanism of action is not completely known, zinc supplementation may be used to increase immunity against viruses or may interfere with the replication of certain viruses, such as the human papillomavirus (HPV).
Biological Half-Life280 days
Metabolism/Metabolites · 2건

Please refer to DrugBank entry [DB01593]

Zinc can enter the body through the lungs, skin, and gastrointestinal tract. Intestinal absorption of zinc is controlled by zinc carrier protein CRIP. Zinc also binds to metallothioneins, which help prevent absorption of excess zinc. Zinc is widely distributed and found in all tissues and tissues fluids, concentrating in the liver, gastrointestinal tract, kidney, skin, lung, brain, heart, and pancreas. In the bloodstream zinc is found bound to carbonic anhydrase in erythrocytes, as well as bound to albumin, _2-macroglobulin, and amino acids in the the plasma. Albumin and amino acid bound zinc can diffuse across tissue membranes. Zinc is excreted in the urine and faeces. (L49)

관련 반응

2건
반응 기록 만들기
HRID 1178164 반응식
HRID 1178164생성물로
HRID 2371659 반응식
HRID 2371659반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
UNII
U6WSN5SQ1Z
EC Number
224-736-9
Nikkaji
J209.087B
물리적 상태
powder to crystal
색상
흰색에서 거의 흰색
수용성
100 g/l에 · 물 100g/l에 용해됩니다.
Merck
14 · 14,4456
화장품 원료 기능
구강 관리항균피부 컨디셔닝탈취제
InChI
InChI=1/2C6H12O7.Zn/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/s3
InChIKey
WHMDKBIGKVEYHS-ATBKJFGMNA-L
SMILES
[C@H](O)([C@H](O)[C@H](O)CO)[C@@H](O)C(=O)O[Zn]OC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO |&1:0,2,4,8,17,19,21,23,r|
LogP
-7.41 at · -7.41 at 20℃
EPA
Zinc, bis(D-gluconato-.kappa.O1,.kappa.O2)-, (T-4)- (4468-02-4)

화학적 성질

White or almost white, hygroscopic, crystalline powder.

USEPA; Ambient Water Quality Criteria Doc: Zinc (1980) EPA 400/5-80-079

USEPA; Ambient Water Quality Criteria Doc: Zinc (1987) EPA 400/5-87-003

Arvidson, B. A Review of Axonal Transport of Metals. Toxicology 88: 1-14 (19994) Recent findings regarding axonal transport of metals, including zinc.

For more Special Reports (Complete) data for ZINC GLUCONATE (6 total), please visit the HSDB record page.

Clean Water Act Requirements · 3건

Toxic pollutant designated pursuant to section 307(a)(1) of the Clean Water Act and is subject to effluent limitations. /Zinc and compounds/

For total recoverable zinc the criterion-to protect freshwater aquatic life ... is 47 ng/l as a 24 hr average ... at hardnesses of 50, 100, and 200 mg/l as CaCO3 the concentration of total recoverable zinc should not exceed 180, 320, 570 ug/l at any time. /Soluble zinc salts/

For total recoverable zinc the criterion to protect saltwater aquatic life ... is 58 ug/l as a 24 hr average and the concentration should not exceed 170 ug/l at any time. /Soluble zinc salts/

Hazard Classes and CategoriesEye Dam. 1 (81.6%)
State Drinking Water Guidelines · 2건

(AZ) ARIZONA 5000 ug/l /Zinc/

(MN) MINNESOTA 2000 ug/l /Zinc/

Federal Drinking Water Guidelines · 2건

EPA 5000 ug/l /Zinc/

EPA 2000 ug/l /Zinc, Lifetime health advisory/

안전 및 보호

Disposal Methods · 1건

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Minimum Risk LevelIntermediate Oral: 0.3 mg/kg/day (L134) Chronic Oral: 0.3 mg/kg/day (L134)

독성 정보

TreatmentZinc poisoning is treated symptomatically, often by administering fluids such as water or milk, or with gastric lavage. (L49)
Interactions · 5건

Large doses of zinc may inhibit copper absorption in the intestine; zinc supplements should be taken at least 2 hours after the administration of copper supplements. /Zinc supplements/

Thiazide diuretics have been found to increase urinary zinc excretion. /Zinc supplements/

Concurrent use of large amounts of fiber, phosphorus, or phytates with zinc supplements may reduce zinc absorption by formation of nonabsorbable complexes; food containing fiber, phosphorus, or phytates should be taken at least 2 hours after zinc supplements. /Zinc supplements/

Some studies have found that folate can decrease the absorption of zinc, but not in the presence of excessive zinc; other studies have found no inhibition. /Zinc supplements/

For more Interactions (Complete) data for ZINC GLUCONATE (8 total), please visit the HSDB record page.

Health EffectsChronic exposure to zinc causes anemia, atazia, lethargy, and decreases the level of good cholesterol in the body. It is also believed to cause pancreatic and reproductive damage. (L49)
Exposure RoutesInhalation (L49) ; oral (L49) ; dermal (L49)
Toxicity Summary · 3건

The CIR Expert Panel concluded that the following 27 zinc salts are safe in cosmetics in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating...Zinc Gluconate...

Safe for use in cosmetics, with qualifications

Anaemia results from the excessive absorption of zinc suppressing copper and iron absorption, most likely through competitive binding of intestinal mucosal cells. Unbalanced levels of copper and zinc binding to Cu,Zn-superoxide dismutase has been linked to amyotrophic lateral sclerosis (ALS). Stomach acid dissolves metallic zinc to give corrosive zinc chloride, which can cause damage to the stomach lining. Metal fume fever is thought to be an immune response to inhaled zinc. (L48, L49, A49)

Signs and Symptoms · 1건

Ingestion of large doses of zinc causes stomach cramps, nausea, and vomiting. Acute inhalation of large amounts of zinc causes metal fume fever, which is characterized by chills, fever, headache, weakness, dryness of the nose and throat, chest pain, and coughing. Dermal contact with zinc results in skin irritation. (L49)

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Probable Routes of Human ExposureUse of zinc gluconate in therapeutic applications will result in exposure in humans. Its use in cold remedies will result in considerable oral exposure in humans. (SRC)

규제 정보

FDA RequirementsThis substance is generally recognized as safe when used as a nutrient and/or dietary supplement in accordance with good manufacturing or feeding practice.
Clean Water Act Requirements · 3건

Toxic pollutant designated pursuant to section 307(a)(1) of the Clean Water Act and is subject to effluent limitations. /Zinc and compounds/

For total recoverable zinc the criterion-to protect freshwater aquatic life ... is 47 ng/l as a 24 hr average ... at hardnesses of 50, 100, and 200 mg/l as CaCO3 the concentration of total recoverable zinc should not exceed 180, 320, 570 ug/l at any time. /Soluble zinc salts/

For total recoverable zinc the criterion to protect saltwater aquatic life ... is 58 ug/l as a 24 hr average and the concentration should not exceed 170 ug/l at any time. /Soluble zinc salts/

State Drinking Water Guidelines · 2건

(AZ) ARIZONA 5000 ug/l /Zinc/

(MN) MINNESOTA 2000 ug/l /Zinc/

Federal Drinking Water Guidelines · 2건

EPA 5000 ug/l /Zinc/

EPA 2000 ug/l /Zinc, Lifetime health advisory/

안전 데이터

tsca
TSCA listed
rtecs
ZH3750000
HS 번호
29181600
기존화학 물질
KE-03160
유해 물질 데이터
4468-02-4(Hazardous Substances Data)
FDA Pharmacological Classification · 4건

ZINC GLUCONATE

Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]

ZINCUM GLUCONICUM

Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]

Absorption, Distribution and Excretion · 4건

Please refer to DrugBank entry [DB01593]

Feces and urine

Stored primarily in skeletal muscle and bone.

Please refer to DrugBank entry [DB01593]

용도 및 제조

Uses · 6건

CIR ingredient: Zinc Gluconate

Used as dietary supplement and food additive; Also used in human and veterinary medicine; [HSDB] Used as a chelating agent, high alkalinity bottle cleanser, finish remover, and in the tanning and textile industries; [Merck Index]

Textiles (Fiber & Fabric Manufacturing) [Category: Industry]

Dietary supplement and food additive

MEDICATION

MEDICATION (VET)

Formulations/Preparations · 3건

Descote zinc gluconate: Microencapsulated beaded powder containing 25% zinc gluconate & 75% edible coating

USP powder, granular & direct compressible grades

USP21 powder & fine granular grades

Household ProductsInformation on 4 consumer products that contain Zinc gluconate in the following categories is provided:
Use ClassificationCosmetics -> Skin conditioning; Deodorant
General Manufacturing InformationZinc, bis(D-gluconato-.kappa.O1,.kappa.O2)-, (T-4)-: ACTIVE
응용 분야 · 1건

용도zinc gluconate helps maintain the skin in good condition and acts as a deodorant by preventing the growth of micro-organisms, such as bacteria, fungi or yeast, in a formulation. Zinc gluconate could also be effectively used in anti-acne products.

상·하류 제품 정보

상류 원료

Gluconate solutionstrongly acidic type cation exchange resin글루콘산칼슘글루콘산산화아연아연 수산화물물글루콘산나트륨
추가 설명 · 3건

순도시험(1) 카드뮴 : 이 품목 5.0g을 취하여 원자흡광광도법 또는 유도결합플라즈마발광광도법에 따라 시험할 때, 그 양은 2.0ppm 이하이어야 한다. (2) 염화물 : 이 품목 0.3g을 취하여 염화물시험법에 따라 시험할 때, 그 양은 0.01N 염산 0.42mL에 대응하는 양 이하이어야 한다. (3) 황산염 : 이 품목 0.49g을 취하여 황산염시험법에 따라 시험할 때, 그 양은 0.01N 황산 0.5mL에 대응하는 양 이하이어야 한다. (4) 납 : 이 품목 5.0g을 취하여 원자흡광광도법 또는 유도결합플라즈마발광광도법에 따라 시험할 때, 그 양은 2.0ppm 이하이어야 한다. (5) 비소 : 이 품목을 비소시험법에 따라 시험할 때, 그 양은 4.0ppm 이하이어야 한다. (6) 환원물질 : 이 품목 약 1g을 정밀히 달아 250mL 삼각플라스크에 넣고 물 10mL를 가하여 이 액에 알칼리구연산동시액 25mL를 가하고 작은 비이커로 마개를 한 후 정확히 5분간 조용히 가열하고 실온으로 급냉한다. 이 액에 초산(1→10) 25mL, 0.1N 요오드용액 10mL, 묽은염산 10mL 및 전분시액 3mL를 가하여 청색이 없어질 때까지 0.1N 치오황산나트륨용액으로 적정할 때, 그 양은 1.0% 이하이어야 한다.V1 : 0.1N 요오드용액의 첨가량(mL)N1 : 0.1N 요오드용액의 규정농도V2 : 0.1N 치오황산나트륨용액의 소비량(mL)N2 : 0.1N 치오황산나트륨용액의 규정농도2.7 : D-글루코오스에 대한 실험적 대응량

확인시험(1) 이 품목의 수용액(1→10)은 확인시험법 중 아연염의 반응을 나타낸다. (2) 「글루콘산나트륨」의 확인시험 (2)에 따라 시험한다.

정량법이 품목 약 0.7g을 정밀히 달아 물 100mL를 가하고 필요하면 가온하여 녹인 후 암모니아‧염화암모늄액 5mL를 가한 후 에리오크롬블랙시액 0.1mL를 가한다. 이 용액이 청색으로 변할 때까지 0.05M 이.디.티.에이.이나트륨용액으로 적정한다.0.05M 이.디.티.에이.이나트륨용액 1mL = 22.78mg C12H22O14Zn